Oncotype DX
Oncotype DX test measures the levels of specific genes that may indicate the presence of cancer cells. This test helps check the risk of recurrence of breast cancer. This test makes use of breast cancer biopsy and studies the patient where the cancer is hormone-receptor positive. Then the Oncotype DX test draws up a recurrence score. A high recurrence score indicates higher chances of cancer recurrence. But this has to be seen along with other factors such as the age of the patient, grade of cancer and size of cancer. This test costs about $3,500. In many cases, the Oncotype DX test helps in deciding whether a woman must go in for chemotherapy and hormonal therapy post surgery for breast cancer. Typically those with low recurrence score may not need to undergo chemotherapy. The Oncotype DX test aids in tailoring treatment to suit the individual needs of each patient.
Tags: #Oncotype DXAt TargetWoman, every page you read is crafted by a team of highly qualified experts — not generated by artificial intelligence. We believe in thoughtful, human-written content backed by research, insight, and empathy. Our use of AI is limited to semantic understanding, helping us better connect ideas, organize knowledge, and enhance user experience — never to replace the human voice that defines our work. Our Natural Language Navigational engine knows that words form only the outer superficial layer. The real meaning of the words are deduced from the collection of words, their proximity to each other and the context.
Diseases, Symptoms, Tests and Treatment arranged in alphabetical order:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Bibliography / Reference
Collection of Pages - Last revised Date: May 30, 2025